Literature DB >> 7443713

Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines.

R E Weibel, E B Buynak, A A McLean, R R Roehm, M R Hilleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7443713     DOI： 10.3181/00379727-165-40967

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  16 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method.

Authors:  Donald R Latner; Marcia McGrew; Nobia J Williams; Sun B Sowers; William J Bellini; Carole J Hickman
Journal:  Clin Vaccine Immunol       Date:  2013-12-26

Review 3.  [Mumps vaccines: virological basis].

Authors:  A Ströhle; D Germann
Journal:  Soz Praventivmed       Date:  1995

4.  Immunity to measles in young adults in Israel.

Authors:  Y Lerman; S Riskin-Mashiach; D Cohen; R Slepon; T Shohat; H Harari; M Wiener; Y L Danon
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

5.  The duration of immunity in cattle following inoculation of rinderpest cell culture vaccine.

Authors:  W Plowright
Journal:  J Hyg (Lond)       Date:  1984-06

6.  Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Authors:  Cheryl Cohen; Joanne M White; Emma J Savage; Judith R Glynn; Yoon Choi; Nick Andrews; David Brown; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

7.  Public health implications of rubella antibody levels in California.

Authors:  L G Dales; J Chin
Journal:  Am J Public Health       Date:  1982-02       Impact factor: 9.308

8.  Immune responses to mumps vaccine in adults who were vaccinated in childhood.

Authors:  Rima Hanna-Wakim; Linda L Yasukawa; Phillip Sung; Ann M Arvin; Hayley A Gans
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

9.  Benefits, risks and costs of immunization for measles, mumps and rubella.

Authors:  C C White; J P Koplan; W A Orenstein
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308

10.  Chapter 8 Paramyxoviruses.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.